15.17
전일 마감가:
$15.23
열려 있는:
$15.09
하루 거래량:
360.60K
Relative Volume:
0.60
시가총액:
$4.14B
수익:
$1.35B
순이익/손실:
$159.12M
주가수익비율:
26.02
EPS:
0.5831
순현금흐름:
$12.86M
1주 성능:
+3.62%
1개월 성능:
-6.93%
6개월 성능:
-43.40%
1년 성능:
-29.70%
Stevanato Group Spa Stock (STVN) Company Profile
Compare STVN vs ISRG, BDX, ALC, MDLN, RMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
|
STVN
Stevanato Group Spa
|
15.17 | 4.16B | 1.35B | 159.12M | 12.86M | 0.5831 |
|
ISRG
Intuitive Surgical Inc
|
479.93 | 169.66B | 10.06B | 2.88B | 2.49B | 7.876 |
|
BDX
Becton Dickinson Co
|
156.53 | 44.97B | 21.92B | 1.76B | 2.63B | 6.1223 |
|
ALC
Alcon Inc
|
75.01 | 36.92B | 10.40B | 980.00M | 1.61B | 1.9749 |
|
MDLN
Medline Inc
|
43.59 | 34.30B | 28.43B | 1.16B | 1.26B | 1.4457 |
|
RMD
Resmed Inc
|
227.41 | 33.20B | 5.40B | 1.49B | 1.78B | 10.12 |
Stevanato Group Spa Stock (STVN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-12-02 | 재개 | Morgan Stanley | Equal-Weight |
| 2024-12-13 | 개시 | Wolfe Research | Outperform |
| 2024-12-03 | 재개 | Morgan Stanley | Equal-Weight |
| 2024-04-22 | 개시 | Exane BNP Paribas | Outperform |
| 2023-11-01 | 다운그레이드 | Jefferies | Buy → Hold |
| 2023-09-26 | 개시 | Stephens | Overweight |
| 2023-09-19 | 개시 | CJS Securities | Market Outperform |
| 2023-08-24 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2021-08-10 | 개시 | BofA Securities | Buy |
| 2021-08-10 | 개시 | Citigroup | Buy |
| 2021-08-10 | 개시 | Jefferies | Buy |
| 2021-08-10 | 개시 | KeyBanc Capital Markets | Overweight |
| 2021-08-10 | 개시 | Morgan Stanley | Overweight |
| 2021-08-10 | 개시 | Wells Fargo | Overweight |
모두보기
Stevanato Group Spa 주식(STVN)의 최신 뉴스
[Form 3] Stevanato Group S.p.A. Initial Statement of Beneficial Ownership - Stock Titan
Stevanato Group (STVN) director Federici discloses direct and indirect share holdings - Stock Titan
Director Morel discloses 33,942 Stevanato (STVN) Ordinary Shares in Form 3 - Stock Titan
Stevanato Group outlines 2026 revenue target up to €1.308B with high-value solutions set to reach 48% of sales - MSN
Stevanato Group (NYSE: STVN) director files Form 3/A with no trades - Stock Titan
Director Lin Sue-Jean discloses 2,000-share stake in Stevanato (STVN) - Stock Titan
Stevanato Group (STVN) director reports holding 65,976 ordinary shares - Stock Titan
Stevanato Group S.p.A (NYSE:STVN) Q4 2025 earnings call transcript - MSN
Stevanato Group (STVN) CFO discloses ordinary share and multi-year RSU holdings - Stock Titan
Stevanato (NYSE: STVN) director details 253M Class A share holding - Stock Titan
Stevanato Group (STVN) executive discloses 404,942 shares and multiple RSU grants - Stock Titan
Director Bonanni reports 119,700 Stevanato (NYSE: STVN) shares - Stock Titan
Meme Stocks: Should value investors consider Stevanato Group SpA2026 Final Week & Weekly Hot Stock Watchlists - baoquankhu1.vn
Can Stevanato Group SpA deliver consistent EPS growth2026 Valuation Update & Entry Point Confirmation Signals - baoquankhu1.vn
Stevanato Group S.P.A. (IT0005452658.SG) Stock Price, News, Quote & History - Yahoo Finance
Here’s Why Artisan Small Cap Fund Remains Invested in Stevanato Group (STVN) - Insider Monkey
Fred Alger Management LLC Reduces Stock Position in Stevanato Group S.p.A. $STVN - MarketBeat
Stevanato secures €200M in financing - MSN
Stevanato Group shares jump nearly 17% after strong fourth-quarter results - MSN
Income Plays: Is Stevanato Group SpA a good ESG investmentMarket Trend Report & Accurate Intraday Trade Tips - baoquankhu1.vn
Stevanato Group: Riding The Biologics Boom—Can Its Injectable Solutions Become The Backbone Of Next-Gen Drug Delivery? - Smartkarma
Stevanato Group S.p.A. (NYSE:STVN) Sees Significant Decline in Short Interest - MarketBeat
KeyBanc cuts Stevanato Group stock price target on GLP-1 outlook - Investing.com Nigeria
Top Stevanato Group (STVN) Competitors 2026 - MarketBeat
Stevanato Group to Participate in the KeyBanc Capital Markets Virtual Healthcare Forum - The National Law Review
Stevanato Group Posts 2025 Growth on High-Value Syringes and GLP‑1 Demand - The Globe and Mail
Earnings Miss: Can Stevanato Group SpA keep up with sector leadersWeekly Trend Recap & Expert Verified Movement Alerts - baoquankhu1.vn
[6-K] Stevanato Group S.p.A. Current Report (Foreign Issuer) | STVN SEC FilingForm 6-K - Stock Titan
(STVN) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
Stevanato Group S.p.A. 2025 Q4ResultsEarnings Call Presentation (NYSE:STVN) 2026-03-10 - Seeking Alpha
Stevanato Group SpA (STVN) Trading 3.05% Higher on Mar 9 - GuruFocus
Stevanato Group Earnings Call Highlights High-Value Surge - TipRanks
Day Trade: Can Stevanato Group SpA keep up with sector leadersJuly 2025 Opening Moves & Free Fast Entry Momentum Trade Alerts - baoquankhu1.vn
Stevanato (STVN) Q4 2025 Earnings Call Transcript - AOL.com
Stevanato Group S.P.A. (IT0005452658.SG) Analyst Insights, Price Targets & Recommendations - Yahoo Finance
Morgan Stanley Has Lowered Expectations for Stevanato Group (NYSE:STVN) Stock Price - MarketBeat
KeyBanc Maintained Overweight for Stevanato Group S.p.A. (STVN) March 2026 - Meyka
Stevanato: Strong Q4 Results Reinforce Long-Term Growth Story - Seeking Alpha
Stevanato Group (NYSE:STVN) Margin Improvement To 12% Tests Bullish Earnings Narratives - Sahm
Stevanato Group Posts Record High‑Value Revenue and Strong 2025 Results, Sets Upbeat 2026 Outlook - The Globe and Mail
STVN: Citigroup Maintains 'Buy' But Lowers Price Target to $26 | - GuruFocus
Stevanato Group (NYSE:STVN) Given New $26.00 Price Target at Citigroup - MarketBeat
Stevanato Group (NYSE:STVN) Stock Price Down 8.5% on Analyst Downgrade - MarketBeat
KeyBanc cuts Stevanato Group stock price target on GLP-1 outlook By Investing.com - Investing.com South Africa
Stevanato Group (NYSE:STVN) Given New $32.00 Price Target at KeyCorp - MarketBeat
Stevanato Group Delivers 7% Revenue Growth for Fiscal Year 2025, Including Record Revenue from High-Value Solutions and Expanded Margins - marketscreener.com
Stevanato Group Soars 18.81%, Hits Intraday High of $17.57 - Markets Mojo
Stevanato Group Opens with 9.5% Gain, Surpassing S&P 500's Decline - Markets Mojo
Stevanato Group S.p.A. (NYSE:STVN) Q4 2025 Earnings Call Transcript - Insider Monkey
Stevanato Group price target lowered to $26 from $32 at Citi - TipRanks
BofA Maintains Buy on Stevanato Group S.p.A. (STVN) March 4, 2026 - Meyka
Stevanato Group Spa (STVN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):